Welcome to OBS

We are a Healthcare group of companies with a strong presence in Pakistan and expansion plans worldwide. Our Group specializes in strategic business alliances with reputed international firms by providing a full range of high quality professional services encompassing from manufacturing to marketing, distribution to sales of pharmaceutical & consumer health products; hence providing its partners opportunity to extend their businesses in Pakistan. The OBS group operates via its 3 sister concerns – OBS Healthcare (Representing Organon part of Schering Plough Portfolio), OBS Pharma & OBS Pakistan (Representing Merck & Co. Inc., USA products).

OBS Healthcare (Representing Organon part of Schering Plough Portfolio) is basically a strategic partner of Organon now part of Schering Plough and holds exclusive manufacturing and marketing rights for Organon only products in Pakistan. From a humble beginning in 1963, OBS Healthcare (Representing Organon part of Schering Plough Portfolio) has now become a name associated with quality medicine throughout Pakistan with strong presence in Gynecology (Contraception, Infertility and Menopause therapy), Psychiatry & Anesthesiology.

After achieving a consistent leading position in most of the specialized therapeutic areas, in 2007 the company via its new sister concern - OBS Pharma has entered into first line therapeutic areas like the Anti-infectives, Anti-Ulcerants & Haematinics, whereby the management aims to provide quality drugs at prices relatively economical. Also the company intends to extend its product portfolio by introducing high quality international consumer health products in Pakistan through strategic collaborations with multinational companies for which it has already signed agreements with two other European companies.

In mid 2008, OBS entered into a new business model with Merck & Co. Inc., USA for acquiring Merck Sharp & Dohme of Pakistan Ltd (MSD Pakistan). Under the agreement between the two companies, MSD Pakistan which includes manufacturing, sales and marketing operations continue as it existed but under the management and ownership of OBS as OBS Pakistan.

In continuation of its rapid pace of expansion in June 2009, OBS further signed a business agreement with Merck & Co. Inc., USA and represent them in Srilanka and now OBS, with its strong marketing and sales muscles is exploring new horizons in Srilanka.

In 2010, OBS also expanded its OBS Pharma division by introducing 5 new high quality medicines in the field of Cardiology and Neuropsychiatry in Pakistan and Srilanka.

Overall in this brief span of 3 years OBS has reached in the top 20 Pharmaceutical companies in Pakistan and is continuously striving to manufacture & market innovative medicines to address unmet medical needs. OBS has its expertise in major health segments like Cardiovascular, Neuro Psychiatry, Anti infective, Respiratory, Gastroenterology, Urology, Vaccines, Ophthalmology, Bone disorder and Endocrinology.